1. Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2013; 24:1783–90.
Article
2. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997; 89:501–6.
Article
3. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008; 300:1311–6.
Article
4. Mant J, Painter R, Vessey M. Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study. Br J Obstet Gynaecol. 1997; 104:579–85.
Article
5. Richter HE, Burgio KL, Clements RH, Goode PS, Redden DT, Varner RE. Urinary and anal incontinence in morbidly obese women considering weight loss surgery. Obstet Gynecol. 2005; 106:1272–7.
Article
6. Erekson EA, Sung VW, Myers DL. Effect of body mass index on the risk of anal incontinence and defecatory dysfunction in women. Am J Obstet Gynecol. 2008; 198:596. e1-4.
Article
7. Leeners B, Geary N, Tobler PN, Asarian L. Ovarian hormones and obesity. Hum Reprod Update. 2017; 23:300–21.
Article
8. Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996; 175:10–7.
Article
9. Yoo EH, Jeon MJ, Ahn KH, Bai SW. Translation and linguistic validation of Korean version of short form of pelvic floor distress inventory-20, pelvic floor impact questionnaire-7. Obstet Gynecol Sci. 2013; 56:330–2.
Article
10. Yoon JL, Cho JJ, Park KM, Noh HM, Park YS. Diagnostic performance of body mass index using the Western Pacific Regional Office of World Health Organization reference standards for body fat percentage. J Korean Med Sci. 2015; 30:162–6.
Article
11. Hunskaar S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn. 2008; 27:749–57.
Article
12. Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002; 186:1160–6.
Article
13. Shalom DF, Lin SN, St Louis S, Winkler HA. Effect of age, body mass index, and parity on Pelvic Organ Prolapse Quantification system measurements in women with symptomatic pelvic organ prolapse. J Obstet Gynaecol Res. 2012; 38:415–9.
Article
14. Giri A, Hartmann KE, Hellwege JN, Velez Edwards DR, Edwards TL. Obesity and pelvic organ prolapse: a systematic review and meta-analysis of observational studies. Am J Obstet Gynecol. 2017; 217:11–26. e3.
Article
15. Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J Pelvic Floor Dysfunct. 2015; 26:1559–73.
Article
16. Uustal Fornell E, Wingren G, Kjølhede P. Factors associated with pelvic floor dysfunction with emphasis on urinary and fecal incontinence and genital prolapse: an epidemiological study. Acta Obstet Gynecol Scand. 2004; 83:383–9.
Article
17. Bradley CS, Zimmerman MB, Wang Q, Nygaard IE; Women’s Health Initiative. Vaginal descent and pelvic floor symptoms in postmenopausal women: a longitudinal study. Obstet Gynecol. 2008; 111:1148–53.
18. Washington BB, Erekson EA, Kassis NC, Myers DL. The association between obesity and stage II or greater prolapse. Am J Obstet Gynecol. 2010; 202:503. e1-4.
Article
19. Foley JT, Lloyd M, Temple VA. Body mass index trends among adult U.S. Special Olympians, 2005-2010. Adapt Phys Activ Q. 2013; 30:373–86.
Article
20. Kim CM, Jeon MJ, Chung DJ, Kim SK, Kim JW, Bai SW. Risk factors for pelvic organ prolapse. Int J Gynaecol Obstet. 2007; 98:248–51.
Article
21. Seo JT, Kim JM. Pelvic organ support and prevalence by Pelvic Organ Prolapse-Quantification (POP-Q) in Korean women. J Urol. 2006; 175:1769–72.
Article